scispace - formally typeset
Open AccessJournal ArticleDOI

Shaping proteostasis at the cellular, tissue, and organismal level.

Ambre Sala, +2 more
- 01 May 2017 - 
- Vol. 216, Iss: 5, pp 1231-1241
TLDR
This review by Morimoto and colleagues examines mechanisms by which protein homeostasis (proteostasis) is achieved in multicellular organisms and discusses the implications for health and disease.
Abstract
The proteostasis network (PN) regulates protein synthesis, folding, transport, and degradation to maintain proteome integrity and limit the accumulation of protein aggregates, a hallmark of aging and degenerative diseases. In multicellular organisms, the PN is regulated at the cellular, tissue, and systemic level to ensure organismal health and longevity. Here we review these three layers of PN regulation and examine how they collectively maintain cellular homeostasis, achieve cell type-specific proteomes, and coordinate proteostasis across tissues. A precise understanding of these layers of control has important implications for organismal health and could offer new therapeutic approaches for neurodegenerative diseases and other chronic disorders related to PN dysfunction.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Natural Products as Modulators of the Proteostasis Machinery: Implications in Neurodegenerative Diseases.

TL;DR: This review will focus on the current knowledge regarding the use of natural products as modulators of different components of the proteostasis machinery within the framework of age-associated neurodegenerative diseases.
Journal ArticleDOI

Modulation of Protein Synthesis by eIF2α Phosphorylation Protects Cell from Heat Stress-Mediated Apoptosis.

TL;DR: It is proposed that transient modulation of protein synthesis by eIF2α phosphorylation has a pivotal role in protecting cells from heat stress-induced apoptosis, and pharmacological agents that promote eIF1αosphorylation or reduce ER stress may contribute to the development of promising therapeutic approaches against heat-related diseases.
Book ChapterDOI

Folding Defects Leading to Primary Hyperoxaluria.

TL;DR: Primary hyperoxalurias can be ranked among protein misfolding disorders, because in most cases the enzymatic deficit is due to the inability of each enzyme to reach its native and functional conformation, and molecules able to improve the folding yield of the enzymes involved in each disease form could represent new therapeutic strategies.
Journal ArticleDOI

Aging: therapeutics for a healthy future

TL;DR: The need for therapeutics that address aging and age-related disorders is acute, but the promise of effective treatments provides huge opportunities that, as a community, the authors all seek to enable effectively as soon as possible.
References
More filters
Journal ArticleDOI

The Ubiquitin System

TL;DR: This review discusses recent information on functions and mechanisms of the ubiquitin system and focuses on what the authors know, and would like to know, about the mode of action of ubi...
Journal ArticleDOI

The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation

TL;DR: The vast majority of proteins that a cell secretes or displays on its surface first enter the endoplasmic reticulum, where they fold and assemble, and only properly assembled proteins advance from the ER to the cell surface.
Journal ArticleDOI

An nrf2/small maf heterodimer mediates the induction of phase ii detoxifying enzyme genes through antioxidant response elements

TL;DR: It is demonstrated that Nrf2 is essential for the transcriptional induction of phase II enzymes and the presence of a coordinate transcriptional regulatory mechanism for phase II enzyme genes and the nrf2-deficient mice may prove to be a very useful model for the in vivo analysis of chemical carcinogenesis and resistance to anti-cancer drugs.
Journal ArticleDOI

Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy

TL;DR: Two genes encode ubiquitin ligases that are potential drug targets for the treatment of muscle atrophy, and mice deficient in either MAFbx orMuRF1 were found to be resistant to atrophy.
Related Papers (5)